Ketalar is an anesthetic drug prescribed by a healthcare provider and administered in a healthcare setting. It is commonly used as a general anesthetic, but can also be used to induce anesthesia or be combined with other anesthetics. This drug is administered as an injection into a vein or muscle. Possible side effects of the drug include vision changes, a rapid heartbeat, and mood changes.
What Is Ketalar?
Ketalar® (ketamine hydrochloride) is a prescription medication approved for use as a general anesthetic during certain medical procedures. It is also approved to induce anesthesia (to "put you under") before other anesthetics are administered, or to be used in combination with other anesthetics. It is given as an injection into a vein or muscle.
Ketalar is considered a Schedule III controlled substance, because it has the potential for abuse. This means there are strict laws and regulations controlling its use.
The active ingredient in Ketalar is ketamine hydrochloride (sometimes abbreviated ketamine HCl, or simply called ketamine). Ketamine is sometimes used illicitly, as a drug of abuse, because of some of its effects. This ingredient is also commonly used in veterinary medicine.
Ketalar is manufactured by JHP Pharmaceuticals, LLC.
How Does Ketalar Work?
It is not entirely known how Ketalar works. It is known that the medicine works on certain brain pathways to quickly produce a general state of anesthesia (loss of sensation and awareness) and pain relief. Unlike many other general anesthetics, Ketalar maintains respiration (breathing) and a normal or slightly increased muscle tone.
Ketamine. Micromedex 2.0 Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare), Inc. Updated periodically. Accessed May 10, 2011.
Lexi-Interact [computer program]. Lexi-Comp, Inc.; May 10, 2011.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 10, 2011.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed May 10, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click